These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3362419)

  • 21. Dextromethorphan protects retina against ischemic injury in vivo.
    Yoon YH; Marmor MF
    Arch Ophthalmol; 1989 Mar; 107(3):409-11. PubMed ID: 2923566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open label trial of dextromethorphan in Huntington's disease.
    Walker FO; Hunt VP
    Clin Neuropharmacol; 1989 Aug; 12(4):322-30. PubMed ID: 2529964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the NMDA-receptor antagonist dextromethorphan in infant rat pneumococcal meningitis.
    Sellner J; Ringer R; Baumann P; Perey MJ; Schmitt B; Leib SL
    Curr Drug Metab; 2008 Jan; 9(1):83-8. PubMed ID: 18220575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dextromethorphan, a common antitussive, reduces kindled amygdala seizures in the rat.
    Feeser HR; Kadis JL; Prince DA
    Neurosci Lett; 1988 Apr; 86(3):340-5. PubMed ID: 3380326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The common antitussive agent dextromethorphan protects against hyperoxia-induced cell death in established in vivo and in vitro models of neonatal brain injury.
    Posod A; Pinzer K; Urbanek M; Wegleiter K; Keller M; Kiechl-Kohlendorfer U; Griesmaier E
    Neuroscience; 2014 Aug; 274():260-72. PubMed ID: 24912029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat.
    Barks JD; Post M; Tuor UI
    Pediatr Res; 1991 Jun; 29(6):558-63. PubMed ID: 1866211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    Graham SH; Chen J; Lan JQ; Simon RP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects.
    Aylward M; Maddock J; Davies DE; Protheroe DA; Leideman T
    Eur J Respir Dis; 1984 May; 65(4):283-91. PubMed ID: 6539224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity.
    Choi DW
    Brain Res; 1987 Feb; 403(2):333-6. PubMed ID: 2881608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients.
    Steinberg GK; Bell TE; Yenari MA
    J Neurosurg; 1996 May; 84(5):860-6. PubMed ID: 8622162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat.
    Hattori H; Morin AM; Schwartz PH; Fujikawa DG; Wasterlain CG
    Neurology; 1989 May; 39(5):713-8. PubMed ID: 2651970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dextromethorphan inhibits NMDA-induced convulsions.
    Ferkany JW; Borosky SA; Clissold DB; Pontecorvo MJ
    Eur J Pharmacol; 1988 Jun; 151(1):151-4. PubMed ID: 3046955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain.
    Keller M; Griesmaier E; Auer M; Schlager G; Urbanek M; Simbruner G; Gressens P; Sárközy G
    Eur J Neurosci; 2008 Feb; 27(4):874-83. PubMed ID: 18279363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxia-ischemia.
    Chumas PD; Del Bigio MR; Drake JM; Tuor UI
    J Neurosurg; 1993 Sep; 79(3):414-20. PubMed ID: 8360739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
    Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
    Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of hyperglycemia on cerebral metabolism during hypoxia-ischemia in the immature rat.
    Vannucci RC; Brucklacher RM; Vannucci SJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):1026-33. PubMed ID: 8784248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in plasma half-life of dextrorphan in rats administered dextromethorphan.
    Ramachander G; Bapatla KR; Emele JF
    J Pharm Sci; 1978 Sep; 67(9):1326-7. PubMed ID: 690847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flunarizine, a calcium channel antagonist, is not neuroprotective when given after hypoxia-ischemia in the infant rat.
    Gunn AJ; Gluckman PD
    Dev Pharmacol Ther; 1991; 17(3-4):205-9. PubMed ID: 1841839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of dextromethorphan on c-fos protein expression during focal cerebral ischemia in rats.
    Bao WL; Lu SD; Cheng JS; Zhang AZ
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):418-20. PubMed ID: 9863163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.